79 related articles for article (PubMed ID: 14767546)
61. Vector-based siRNA delivery strategies for high-throughput screening of novel target genes.
Chen M; Du Q; Zhang HY; Wahlestedt C; Liang Z
J RNAi Gene Silencing; 2005 Jul; 1(1):5-11. PubMed ID: 19771198
[TBL] [Abstract][Full Text] [Related]
62. Novel rapid tissue lysis method to evaluate cancer proteins: correlation between elevated Bcl-X(L) expression and colorectal cancer cell proliferation.
Chen WS; Chang HY; Chang JT; Liu JM; Li CP; Chen LL; Chang HL; Chen CC; Huang TS
World J Gastroenterol; 2005 Sep; 11(33):5162-8. PubMed ID: 16127746
[TBL] [Abstract][Full Text] [Related]
63. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo.
Zhang Y; Wang Y; Gao W; Zhang R; Han X; Jia M; Guan W
Breast Cancer Res Treat; 2006 Apr; 96(3):267-77. PubMed ID: 16341821
[TBL] [Abstract][Full Text] [Related]
64. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA.
Hao JH; Gu QL; Liu BY; Li JF; Chen XH; Ji YB; Zhu ZG; Lin YZ
Chin Med J (Engl); 2007 Dec; 120(23):2105-11. PubMed ID: 18167184
[TBL] [Abstract][Full Text] [Related]
66. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
[TBL] [Abstract][Full Text] [Related]
67. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
[TBL] [Abstract][Full Text] [Related]
68. Bcl-2 targeting siRNA expressed by a T7 vector system inhibits human tumor cell growth in vitro.
Holle L; Hicks L; Song W; Holle E; Wagner T; Yu X
Int J Oncol; 2004 Mar; 24(3):615-21. PubMed ID: 14767546
[TBL] [Abstract][Full Text] [Related]
69. Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review.
Jagani H; Kasinathan N; Meka SR; Josyula VR
Artif Cells Nanomed Biotechnol; 2016 Aug; 44(5):1212-21. PubMed ID: 25801037
[TBL] [Abstract][Full Text] [Related]
70. Time depended Bcl-2 inhibition might be useful for a targeted drug therapy.
Talaiezadeh A; Jalali F; Galehdari H; Khodadadi A
Cancer Cell Int; 2015; 15():105. PubMed ID: 26535028
[TBL] [Abstract][Full Text] [Related]
71.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
